Karim Bordji
- Molecular Biology top 10%
- Pharmacology top 2%
- Rheumatology top 5%
- Physiology top 10%
- Cancer Research top 10%
- Co-authors
- Arnaud BianchiPatrick NetterMichel DauçaBernard TerlainAlain BuissonJavier Becerril-OrtegaBertrand LiagreJean-Noël Gouze
- Topics
- NF-κB Signaling Pathways (6 papers)Inflammatory mediators and NSAID effects (5 papers)Cancer, Hypoxia, and Metabolism (4 papers)
In The Last Decade
Karim Bordji
27 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 122
- Molecular Biology 966
- Pharmacology 374
- Rheumatology 314
- Physiology 277
- Cancer Research 254
Countries citing papers authored by Karim Bordji
This map shows the geographic impact of Karim Bordji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karim Bordji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karim Bordji more than expected).
Fields of papers citing papers by Karim Bordji
This network shows the impact of papers produced by Karim Bordji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karim Bordji. The network helps show where Karim Bordji may publish in the future.
Co-authorship network of co-authors of Karim Bordji
This figure shows the co-authorship network connecting the top 25 collaborators of Karim Bordji. A scholar is included among the top collaborators of Karim Bordji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karim Bordji. Karim Bordji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 22 | |
| 2 | 83 | |
| 3 | 28 | |
| 4 | 103 | |
| 5 | 64 | |
| 6 | 154 | |
| 7 | 76 | |
| 8 | 179 | |
| 9 | 29 | |
| 10 | 9 | |
| 11 | 79 | |
| 12 | 169 | |
| 13 | 87 | |
| 14 | 3 | |
| 15 | 133 | |
| 16 | 153 | |
| 17 | 118 | |
| 18 | 29 | |
| 19 | 157 | |
| 20 | 70 |
About Karim Bordji
Karim Bordji is a scholar working on Cancer Research, Pharmacology and Biotechnology, having authored 27 papers that have together received 2.1k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (6 papers), Inflammatory mediators and NSAID effects (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Pharmacology (374 citations), Rheumatology (314 citations) and Cancer Research (254 citations). Karim Bordji has collaborated with scholars based in France, Germany and Morocco. Frequent co-authors include Arnaud Bianchi, Patrick Netter, Michel Dauça, Bernard Terlain, Alain Buisson, Javier Becerril-Ortega, Bertrand Liagre, Jean-Noël Gouze, Jacques Magdalou and Cécile Corbière. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.